Dr. James E Bright, MD

NPI: 1235242454
Total Payments
$949.72
2018 Payments
$144.72
Companies
10
Transactions
63
Medicare Patients
486
Medicare Billing
$96,789

Payment Breakdown by Category

Food & Beverage$940.98 (99.1%)
Education$8.74 (0.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $940.98 60 99.1%
Education $8.74 3 0.9%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $226.67 17 $0 (2018)
Allergan Inc. $215.46 8 $0 (2017)
Otsuka America Pharmaceutical, Inc. $147.91 13 $0 (2018)
Lundbeck LLC $108.05 9 $0 (2017)
Takeda Pharmaceuticals America, Inc. $75.74 5 $0 (2017)
Janssen Pharmaceuticals, Inc $72.37 4 $0 (2017)
Merck Sharp & Dohme Corporation $45.21 3 $0 (2017)
Shire North American Group Inc $33.04 2 $0 (2017)
Arbor Pharmaceuticals, Inc. $13.97 1 $0 (2017)
Pernix Therapeutics Holdings, Inc. $11.30 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2018 $144.72 10 Sunovion Pharmaceuticals Inc. ($100.76)
2017 $805.00 53 Allergan Inc. ($215.46)

All Payment Transactions

63 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
02/23/2017 Lundbeck LLC TRINTELLIX (Drug) Food and Beverage Cash or cash equivalent $13.98 General
Category: PSYCHIATRY
02/21/2017 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $17.75 General
Category: CNS
02/16/2017 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.36 General
Category: NEUROSCIENCE
02/09/2017 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.50 General
Category: PSYCHIATRY
02/07/2017 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $93.15 General
Category: NEUROSCIENCE
01/31/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $13.12 General
Category: NEUROSCIENCE
01/31/2017 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Education In-kind items and services $3.49 General
Category: PSYCHIATRY
01/26/2017 Janssen Pharmaceuticals, Inc INVEGA TRINZA (Drug), INVEGA SUSTENNA Food and Beverage In-kind items and services $13.65 General
Category: Neuroscience
01/24/2017 Takeda Pharmaceuticals America, Inc. Trintellix (Drug) Food and Beverage In-kind items and services $11.36 General
Category: Central Nervous System (CNS)
01/12/2017 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.61 General
Category: NEUROSCIENCE
01/05/2017 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.00 General
Category: CNS
01/03/2017 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.21 General
Category: PSYCHIATRY
01/03/2017 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $1.30 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 110 422 $56,970 $22,555
2022 2 129 454 $63,990 $25,305
2021 1 118 471 $62,001 $26,017
2020 1 129 524 $66,024 $22,912
Total Patients
486
Total Services
1,871
Medicare Billing
$96,789
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 110 422 $56,970 $22,555 39.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 117 442 $59,670 $23,498 39.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 12 12 $4,320 $1,807 41.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 118 471 $62,001 $26,017 42.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 129 524 $66,024 $22,912 34.7%

About Dr. James E Bright, MD

Dr. James E Bright, MD is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235242454.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James E Bright, MD has received a total of $949.72 in payments from pharmaceutical and medical device companies, with $144.72 received in 2018. These payments were reported across 63 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($940.98).

As a Medicare-enrolled provider, Bright has provided services to 486 Medicare beneficiaries, totaling 1,871 services with total Medicare billing of $96,789. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Springfield, MO
  • Active Since 08/15/2006
  • Last Updated 03/27/2018
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1235242454

Products in Payments

  • LATUDA (Drug) $226.67
  • VRAYLAR (Drug) $215.46
  • ABILIFY MAINTENA (Drug) $103.08
  • REXULTI (Drug) $89.12
  • Trintellix (Drug) $75.74
  • TRINTELLIX (Drug) $58.51
  • INVEGA TRINZA (Drug) $42.24
  • VYVANSE (Drug) $33.04
  • INVEGA SUSTENNA (Drug) $30.13
  • BELSOMRA (Drug) $27.02
  • Evekeo (Drug) $13.97
  • SILENOR (Drug) $11.30
  • SAMSCA (Drug) $5.25

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Springfield